Re: Best methods, criteria to assess Biotech stocks?

In my opinion, Prohost is as good as it gets for relative information on the best biotech stocks, but in terms of picking what is hot, you must look at the various market sectors daily to see what is "in vogue" at the time. For example, right now banks and petroleum are very active and hot. Every sector goes through phases of hot and cold. Following the S&P 500 and Nasdaq 100 daily helps identify what the market timing is. Timing is everything in the market. I invest in biotech, but stick to the philosophy of buying stocks that go up in price and have good value. Right now for example, I feel GZMO is one biotech with good value and is underpriced. It is only underpriced because this sector is not hot right now. I would use this time to accumulate good valued biotechs and be patient for them to have there day. We are in a big bear market now and it is not easy to find hot stocks consistently. a good measure of an upturn in the market is when you see two straight weeks of rises in the S&P 500 index without a downturn. This signals a good uptrending market and then I feel we'll see biotechs come into vogue. Right now even the Biotech mutual funds are extremely varied in their growth so even the pros can't pick 'em all the time.

Please Note: This discussion is open to all site visitors and is not regulated by Prohost. Information posted in the discussion should not be considered to be coming from Prohost Research.

Prohost is an independent publication providing information on biotech companies. Prohost does not accept compensation from companies that are featured or profiled. It is strongly recommended that any purchase or sale decisions to any of the featured companies be discussed with a financial advisor or broker prior to completing any such purchase or sale decision. All statements or expressions are the opinion of Prohost and are not meant to be a solicitation or recommendation to buy, sell, or hold securities. Investing in embryonic companies, micro-cap and growth securities is highly speculative and carries a high degree of risk. It is possible that an investor can lose all of his/her investment in this type of companies that are profiled. The information that Prohost relies on is either through the profiled company, news services, research reports, interviews, or other outside sources that Prohost believes are reliable. Prohost makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure of the profiled companies and accepts no responsibilities for inaccuracies or misleading content in any material supplied by those clients. There can be no assurance that future events relating to the profiled company will occur as anticipated. The information contained herein is provided as an information service only. Past performance of featured companies does not guarantee the future success of any currently featured or profiled company. We encourage our readers to invest carefully and read the investor information provided by the Securities and Exchange Commission ("SEC") and/or the National Association of Securities Dealers ("NASD"). We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.

Prohost Biotechnology Online

The Newsletter of Biotechnology Research and Investment

P R O H O S T O n l i n e
The Newsletter of Biotechnology Insight and Investment

Biotechnology Discussion